{"url":"https://lda.senate.gov/api/v1/filings/367bd66e-005a-421c-a836-7eeeb98f54cf/","filing_uuid":"367bd66e-005a-421c-a836-7eeeb98f54cf","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2009,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/367bd66e-005a-421c-a836-7eeeb98f54cf/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Brad Prewitt, President","dt_posted":"2009-04-17T16:21:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"P. O. Box 1404","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Tupelo","registrant_state":"MS","registrant_zip":"38804","registrant":{"id":89097,"url":"https://lda.senate.gov/api/v1/registrants/89097/","house_registrant_id":36350,"name":"PREWITT GROUP, P.A.","description":"Government Affairs Consulting","address_1":"P. O. Box 1404","address_2":null,"address_3":null,"address_4":null,"city":"Tupelo","state":"MS","state_display":"Mississippi","zip":"38804","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"R. BRADLEY PREWITT","contact_telephone":"+1 662-401-3431","dt_updated":"2026-07-26T16:09:24.904195-04:00"},"client":{"id":174012,"url":"https://lda.senate.gov/api/v1/clients/174012/","client_id":1003097,"name":"QUANTALIFE INCORPORATED","general_description":"Company focused on molecular diagnostics market","client_government_entity":false,"client_self_select":false,"state":"CO","state_display":"Colorado","country":"US","country_display":"United States of America","ppb_state":"CO","ppb_state_display":"Colorado","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-03-01"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Advocate for the distribution of FY 09 Defense Appropriations funds noted in the Bill/Report in DTRA, chem./bio defense program line 14, which will go out as a BAA for molecular diagnostic detection technology  real time PCR; FY 10 Defense Appropriations request  for molecular diagnostic detection technology  real time PCR;\n\nFY 10 HHS/HRSA appropriations ruquest for the Tupelo hospital and Lee County to receive funding to buy lab equipment to support the companys research and development efforts;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":6494,"prefix":"mr","prefix_display":"MR.","first_name":"R","nickname":null,"middle_name":"BRADLEY","last_name":"PREWITT","suffix":null,"suffix_display":null},"covered_position":"Counsel, Sen. Cochran","new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}